CompoAtlas

Ultivite Women's 50+ Multivitamin Tablets

Supplement recorded in Open Food Facts

Ultivite Women's 50+ Multivitamin Tablets (Swisse): ingredient list recorded on 10 June 2026. Food supplement : 23 vitamins or minerals, 12 plantes, 16 other ingredients. The daily dose is not stated: the quantities read cannot establish whether a daily dose is met or exceeded. See the references below.

This collaborative Open Food Facts record is dated: the date relates to an update of the record, rather than a formula check. The formula may have changed. Check the packaging. This product is not necessarily declared in France: Compl'Alim declarations are separate.

Open Food Facts: food supplements with a barcode and an ingredient list, retrieved 15 November 2026.

Data “Open Food Facts and its contributors”, licensed under ODbL 1.0; derived table distributed under the same licence.

Brand
Swisse
Barcode
93566780
Countries listed in the record
Australia, New Caledonia
Package quantity
60 pcs
Record date
10 June 2026

Open Food Facts record; Compl'Alim declarations in France.

Ingredient list as published

EACH FILM COATED TABLET CONTAINS:Biotin 150 g; Folic Acid 500 g; Nicotinamide 25 mg; Vitamin A (retinol acetate) 750 g/RE; Vitamin B1 (thiamine from thiamine hydrochloride) 22.03 mg; Vitamin B2 (riboflavin) 30 mg; Vitamin B5 (pantothenic acid from calcium pantothenate) 40 mg; Vitamin B6 (pyridoxine from pyridoxine hydrochloride) 24.68 mg; Vitamin B12 (cyanocobalamin) 50 g; Vitamin C (ascorbic acid) 165 mg; Vitamin D3 (colecalciferol) 25 g; Vitamin E (d-alpha-tocopheryl acid succinate) 41.33 mg; Calcium (from calcium citrate tetrahydrate) 42 mg; Chromium (from chromium picolinate) 50 g; Copper (from copper gluconate) 1.2 mg; Iodine (from potassium iodide) 150 g; Iron (from ferrous fumarate) 5 mg; Magnesium (from heavy magnesium oxide) 105 mg; Manganese (from manganese amino acid chelate) 3.5 mg; Molybdenum (from molybdenum trioxide) 45 g; Potassium (from potassium sulfate) 4 mg; Selenium (from selenomethionine) 50 g; Zinc (from zinc sulfate monohydrate) 5 mg; Co-enzyme Q10 (ubidecarenone) 3 mg; Lutein 1 mg; Silicon (from colloidal anhydrous silica) 9.33 mg; Spearmint Oil 2 mg; Ashwagandha (Withania somnifera extract 50 mg) equiv. dry root 500 mg; Astragalus (Astragalus membranaceus extract 5 mg) equiv. dry root 50 mg; Bilberry (Vaccinium myrtillus extract 1 mg) equiv. fresh fruit 100 mg; Black Cohosh (Actaea racemosa extract 40 mg) equiv. dry root & rhizome 200 mg; Cranberry (Vaccinium macrocarpon fruit powder 20 mg) equiv. fresh fruit 1000 mg; Ginger (Zingiber officinale extract 3 mg) equiv. dry rhizome 15 mg; Ginkgo (Ginkgo biloba extract 20 mg) equiv. dry leaf 1000 mg; Globe Artichoke (Cynara scolymus extract 1 mg) equiv. fresh leaf 50 mg; Grape Seed (Vitis vinifera extract 9.9 mg) equiv. dry seed 1.18 g; Milk Thistle (Silybum marianum extract 21.43 mg) equiv. dry fruit 1.5 g; Turmeric (Curcuma longa extract 5 mg) equiv. dry rhizome 112.5 mg; Water Hyssop (Bacopa monnieri extract 1.25 mg) equiv. dry herb 50 mg.Note: g micrograms.

Open Food Facts: food supplements with a barcode and an ingredient list, retrieved 15 November 2026.

Data “Open Food Facts and its contributors”, licensed under ODbL 1.0; derived table distributed under the same licence.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vitamin D3 (colecalciferol)
    Read the warning, when it applies and the studies cited

    VITAMIN D (>1,000 - 2,500 IU)

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).

    Sources cited by Health Canada (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).

    Sources cited by Health Canada (3)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NNHPD 2021. Natural and Non-Prescription Health Products Directorate. Internal evidence and HC's product monographs.
    • DPSNSO 2021. Direction des produits de santé naturels et sans ordonnance. Preuves internes et monographies de produits internes de SC.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.

    Applies to products containing vitamin K2.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).

    Sources cited by Health Canada (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).

    Sources cited by Health Canada (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Contraindications

    Condition of application: All products.

    Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).

    Sources cited by Health Canada (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Applies to products containing zinc sourced from picolinate.

    Do not use if you are pregnant or breastfeeding (NNHPD 2026).

    Sources cited by Health Canada (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Known adverse reactions

    Condition of application: All products.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).

    Sources cited by Health Canada (2)
    • BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
    • NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

    Applies to products providing more than 350 mg of magnesium per day.

    When using this product you may experience diarrhea (NNHPD 2026).

    Sources cited by Health Canada (2)
    • NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
    • DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre

    Health Canada monograph dated 26 June 2026

  • Ashwagandha (Withania somnifera extract 50 mg) equiv
    Read the warning, when it applies and the studies cited

    ASHWAGANDHA - WITHANIA SOMNIFERA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).

    Sources cited by Health Canada (3)
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).

    Sources cited by Health Canada (3)
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
    • Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.

    Health Canada monograph dated 28 February 2025

  • Astragalus (Astragalus membranaceus extract 5 mg) equiv
    Read the warning, when it applies and the studies cited

    ASTRAGALUS - ASTRAGALUS MEMBRANACEUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Astragalus Root. Santa Cruz (CA): American Herbal Pharmacopoeia; 1999.

    Contraindications

    Condition of application: Traditional Chinese Medicine.

    Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).

    Sources cited by Health Canada (2)
    • Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
    • Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.

    Health Canada monograph dated 30 May 2025

  • Bilberry (Vaccinium myrtillus extract 1 mg) equiv
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

  • Black Cohosh (Actaea racemosa extract 40 mg) equiv
    Read the warning, when it applies and the studies cited

    Black Cohosh - Actaea Racemosa

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver disorder or develop symptoms of liver trouble (EMA 2018, 2007; Lynch et al. 2006; Mills et al. 2006; Cohen et al. 2004; NIH 2004).

    Sources cited by Health Canada (6)
    • Cohen SM, O'Connor AM, Hart J, Merel NH, Te HS. Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause: the Journal of the North American Menopause Society 2004;11(5):575-577. PubMed Case report
    • EMA 2018: European Medicines Agency. Committee on Herbal Medicinal Products (HMPC). European Union Herbal monograph on Cimicifuga racemosa (L.) Nutt., rhizome. March 2018. [Accessed 2025 January 3]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-cimicifuga-racemosa-l-nutt-rhizome-revision-1_en.pdf
    • EMA 2007: European Medicines Agency. Committee on Herbal Medicinal Products (HMPC) Annex 1. Assessment of case reports connected to herbal medicinal products containing Cimicifugae racemosae rhizoma (Black cohosh, root). London (UK): European Medicines Agency; May 20027. [Accessed 2025 January 3]. Available from: https://www.ema.europa.eu/en/documents/herbal-report/assessment-case-reports-connected-herbal-medicinal-products-containing-cimicifugae-racemosae-rhizoma-black-cohosh-root_en.pdf
    • Lynch CR, Folkers ME, Hutson WR. Fulminant hepatic failure associated with the use of black cohosh: a case report. Liver Transplantation 2006;12(6):989-992. PubMed Case report
    • Mills E, Duguoa J, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation. New York (NY): Taylor and Francis; 2006.
    • NIH 2004: National Institutes of Health. Workshop on the Safety of Black Cohosh in Clinical Studies. Bethesda (MD): National Institutes of Health, Department of Health and Human Services; November 22, 2004. [Accessed 2024 December 3]. Available from: https://files.nccih.nih.gov/s3fs-public/news/blackcohosh_mtngsumm.pdf

    Contraindications

    Do not use if you are pregnant (Brinker 2010; Hoffmann 2003; Tilgner 1999).

    Sources cited by Health Canada (3)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
    • Tilgner S. Herbal Medicine from the Heart of the Earth Creswell (OR): Wise Acre Press; 1999.

    Health Canada monograph dated 31 January 2025

  • Cranberry (Vaccinium macrocarpon fruit powder 20 mg) equiv
    Read the warning, when it applies and the studies cited

    CRANBERRY - VACCINIUM MACROCARPON

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).

    Sources cited by Health Canada (2)
    • Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CYC, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. The Journal of Urology 2005;174(2):590-594. PubMed Randomised trial
    • Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57(1):26-29. PubMed

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).

    Sources cited by Health Canada (4)
    • Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006;26(9):1314-1319. PubMed
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Grant P. Warfarin and cranberry juice: an interaction? The Journal of Heart Valve Disease 2004;13(1):25-26. PubMed Case report
    • Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. American Journal of Therapeutics 2005;13(3):283-284.

    Condition of application: (Recurrent) urinary tract infection.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 27 March 2026

    DRIED CRANBERRY JUICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).

    Sources cited by Health Canada (2)
    • Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CYC, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. The Journal of Urology 2005;174(2):590-594. PubMed Randomised trial
    • Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57(1):26-29. PubMed

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).

    Sources cited by Health Canada (4)
    • Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006;26(9):1314-1319. PubMed
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Grant P. Warfarin and cranberry juice: an interaction? The Journal of Heart Valve Disease 2004;13(1):25-26. PubMed Case report
    • Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. American Journal of Therapeutics 2005;13(3):283-284.

    Condition of application: (Recurrent) urinary tract infection.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 27 March 2026

  • Ginger (Zingiber officinale extract 3 mg) equiv
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

  • Ginkgo (Ginkgo biloba extract 20 mg) equiv
    Read the warning, when it applies and the studies cited

    GINKGO - GINKGO BILOBA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).

    Sources cited by Health Canada (3)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
    • WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
    • OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Contraindications

    Do not use if you are having a surgery (Gardner and McGuffin 2013).

    Sources cited by Health Canada (1)
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).

    Sources cited by Health Canada (3)
    • Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Health Canada monograph dated 25 July 2025

  • Milk Thistle (Silybum marianum extract 21.43 mg) equiv
    Read the warning, when it applies and the studies cited

    MILK THISTLE - SILYBUM MARIANUM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills et al. 2006).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills E, Dugoua J, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation : An Evidence-Based Approach. London (UK): Taylor and Francis Medical; 2006.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Geier et al. 1990; Mironets et al. 1990).

    Sources cited by Health Canada (2)
    • Geier J, Fuchs Th, Wahl R. [Anaphylactic shock due to an extract of Silybum marianum in a patient with immediate-type allergy to Kiwi fruit]. Anaphylaktischer Schock durch einen Mariendistel-Extrakt bei Soforttyp-Allergie auf Kiwi. Allergologie 1990;13(10):387-388 (in German).
    • Mironets VI, Krasovskaia EA, Polischuk II. [A case of urticaria during carsil treatment]. Vrachebnoe Delo 1990;(7):86-87 (in Russian).

    Health Canada monograph dated 26 June 2026

  • Turmeric (Curcuma longa extract 5 mg) equiv
    Read the warning, when it applies and the studies cited

    TURMERIC - CURCUMA LONGA - Oral

    Route of administration: Oral (ESCOP 2003; Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).

    Sources cited by Health Canada (2)
    • ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).

    Sources cited by Health Canada (6)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2018. European Medicines Agency. European Union herbal monograph on Curcuma longa L., rhizome. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 25 September 2018. [Accessed 2023 October 14] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revision-1_en.pdf
    • ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).

    Sources cited by Health Canada (2)
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).

    Sources cited by Health Canada (2)
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Condition of application: All uses except for Source of antioxidants and Hepatoprotectant.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 26 September 2025

    Turmeric -CURCUMA LONGA - Topical

    Cautions and warnings

    For external use only.

    When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Contraindications

    Do not use on deep or puncture wounds, animal bites or serious burns.

    Health Canada monograph dated 28 February 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Download the derived table under ODbL 1.0 (photo transcriptions under CC BY-SA 3.0).

Composition analysis

Food supplement: the checks below follow French and EU rules and are in French.

Food supplement : 23 vitamins or minerals, 12 plantes, 16 other ingredients. The daily dose is not stated: the quantities read cannot establish whether a daily dose is met or exceeded. See the references below.

For a complete answer, add the daily dose stated on the packaging to the end of the text (for example, ‘1 capsule per day’) and the quantity table (‘per 2 capsules: vitamin C 80 mg…’), or paste the product page link in the ‘link’ field below: we read the list, table and dose from it.

A food supplement is read differently from a cosmetic: daily doses and plants are what matter. References: maximum dose per supplement in France (Order of 9 May 2006, not revised since November 2006), EFSAEuropean Food Safety Authority. safety limit for adults, list of authorised plants (Order of 24 June 2014).

Each row: the printed name, what we recognise (click for its page), the dose read, then its role in the product and the references that apply.

On the labelRecognised asDose readWhat to know
EACH FILM COATED TABLET CONTAINS:BiotinOther ingredient, not identified in our sources150 gAmount read: 150 g. Daily basis unknown: no comparison with daily reference values.
Folic AcidFolates (vitamine B9)500 gAmount read: 500 g. Daily basis unknown: no comparison with daily reference values.
French reference: maximum dose of 200 µg a day (Order of 9 May 2006, not revised since November 2006).
EFSA reference for adults: 1,000 µg a day, food included (safety limit).
NicotinamideNicotinamide (vitamine B3)25 mgAmount read: 25 mg. Daily basis unknown: no comparison with daily reference values.
French reference: maximum dose of 54 mg a day (Order of 9 May 2006, not revised since November 2006).
EFSA reference for adults: 900 mg a day, food included (safety limit).
Vitamin A (retinol acetate) 750 g/REVitamine Anot statedDose not read: compare the one on the label with the references on the nutrient’s page.
Vitamin B1 (thiamine from thiamine hydrochloride)Vitamine B1 (thiamine)22.03 mgAmount read: 22.03 mg. Daily basis unknown: no comparison with daily reference values.
Vitamin B2 (riboflavin)Vitamine B2 (riboflavine)30 mgAmount read: 30 mg. Daily basis unknown: no comparison with daily reference values.
Vitamin B5 (pantothenic acid from calcium pantothenate)Acide pantothénique (vitamine B5)40 mgAmount read: 40 mg. Daily basis unknown: no comparison with daily reference values.
Vitamin B6 (pyridoxine from pyridoxine hydrochloride)Vitamine B624.68 mgAmount read: 24.68 mg. Daily basis unknown: no comparison with daily reference values.
French reference: maximum dose of 2 mg a day (Order of 9 May 2006, not revised since November 2006).
EFSA reference for adults: 12 mg a day, food included (safety limit).
Vitamin B12 (cyanocobalamin)Vitamine B1250 gAmount read: 50 g. Daily basis unknown: no comparison with daily reference values.
Vitamin C (ascorbic acid)Vitamine C165 mgAmount read: 165 mg. Daily basis unknown: no comparison with daily reference values.
French reference: maximum dose of 180 mg a day (Order of 9 May 2006, not revised since November 2006).
Vitamin D3 (colecalciferol)Vitamine D25 gAmount read: 25 g. Daily basis unknown: no comparison with daily reference values.
French reference: maximum dose of 5 µg a day (Order of 9 May 2006, not revised since November 2006).
EFSA reference for adults: 100 µg a day, food included (safety limit).
Vitamin E (d-alpha-tocopheryl acid succinate)Vitamine E41.33 mgAmount read: 41.33 mg. Daily basis unknown: no comparison with daily reference values.
French reference: maximum dose of 30 mg a day (Order of 9 May 2006, not revised since November 2006).
EFSA reference for adults: 300 mg a day, food included (safety limit).
Calcium (from calcium citrate tetrahydrate)Calcium42 mgAmount read: 42 mg. Daily basis unknown: no comparison with daily reference values.
French reference: maximum dose of 800 mg a day (Order of 9 May 2006, not revised since November 2006).
EFSA reference for adults: 2,500 mg a day, food included (safety limit).
Chromium (from chromium picolinate)Chrome50 gAmount read: 50 g. Daily basis unknown: no comparison with daily reference values.
French reference: maximum dose of 25 µg a day (Order of 9 May 2006, not revised since November 2006).
Copper (from copper gluconate)Cuivre1.2 mgAmount read: 1.2 mg. Daily basis unknown: no comparison with daily reference values.
French reference: maximum dose of 2,000 µg a day (Order of 9 May 2006, not revised since November 2006).
EFSA reference for adults: 5 mg a day, food included (safety limit).
Iodine (from potassium iodide)Iode150 gAmount read: 150 g. Daily basis unknown: no comparison with daily reference values.
French reference: maximum dose of 150 µg a day (Order of 9 May 2006, not revised since November 2006).
EFSA reference for adults: 600 µg a day, food included (safety limit).
Iron (from ferrous fumarate)Fer5 mgAmount read: 5 mg. Daily basis unknown: no comparison with daily reference values.
French reference: maximum dose of 14 mg a day (Order of 9 May 2006, not revised since November 2006).
EFSA reference for adults: 40 mg a day, food included (safe level).
Magnesium (from heavy magnesium oxide)Magnésium105 mgAmount read: 105 mg. Daily basis unknown: no comparison with daily reference values.
French reference: maximum dose of 300 mg a day (Order of 9 May 2006, not revised since November 2006).
EFSA reference for adults: 250 mg a day, food included (safety limit).
Manganese (from manganese amino acid chelate)Manganèse3.5 mgAmount read: 3.5 mg. Daily basis unknown: no comparison with daily reference values.
French reference: maximum dose of 3.5 mg a day (Order of 9 May 2006, not revised since November 2006).
EFSA reference for adults: 8 mg a day, food included (safe level).
Molybdenum (from molybdenum trioxide)Molybdène45 gAmount read: 45 g. Daily basis unknown: no comparison with daily reference values.
French reference: maximum dose of 150 µg a day (Order of 9 May 2006, not revised since November 2006).
EFSA reference for adults: 0.6 mg a day, food included (safety limit).
Potassium (from potassium sulfate)Potassium4 mgAmount read: 4 mg. Daily basis unknown: no comparison with daily reference values.
French reference: maximum dose of 80 mg a day (Order of 9 May 2006, not revised since November 2006).
Selenium (from selenomethionine)Sélénium50 gAmount read: 50 g. Daily basis unknown: no comparison with daily reference values.
French reference: maximum dose of 50 µg a day (Order of 9 May 2006, not revised since November 2006).
EFSA reference for adults: 255 µg a day, food included (safety limit).
Zinc (from zinc sulfate monohydrate)Zinc5 mgAmount read: 5 mg. Daily basis unknown: no comparison with daily reference values.
French reference: maximum dose of 15 mg a day (Order of 9 May 2006, not revised since November 2006).
EFSA reference for adults: 25 mg a day, food included (safety limit).
Co-enzyme Q10 (ubidecarenone)Other ingredient, not identified in our sources3 mgAmount read: 3 mg. Daily basis unknown: no comparison with daily reference values.
LuteinOther ingredient, not identified in our sources1 mgAmount read: 1 mg. Daily basis unknown: no comparison with daily reference values.
Silicon (from colloidal anhydrous silica)Silicium9.33 mgAmount read: 9.33 mg. Daily basis unknown: no comparison with daily reference values.
Spearmint OilOther ingredient, not identified in our sources2 mgAmount read: 2 mg. Daily basis unknown: no comparison with daily reference values.
Ashwagandha (Withania somnifera extract 50 mg) equivWithania somnifera (L.) Dunalnot statedWithania somnifera (L.) Dunal is not on the plant list of the Order of 24 June 2014: this is not a prohibition (a product legally sold in another Union country may contain it).
ANSES opinion of 19 April 2024 on this plant: see its page.
BfR opinion of 10 September 2024 on this plant: see its page.
dry rootOther ingredient, not identified in our sources500 mgAmount read: 500 mg. Daily basis unknown: no comparison with daily reference values.
Astragalus (Astragalus membranaceus extract 5 mg) equivAstragalus membranaceus Moenchnot statedAstragalus membranaceus Moench is on the list of plants allowed in food supplements (Order of 24 June 2014).
dry rootOther ingredient, not identified in our sources50 mgAmount read: 50 mg. Daily basis unknown: no comparison with daily reference values.
Bilberry (Vaccinium myrtillus extract 1 mg) equivVaccinium myrtillus L.not statedVaccinium myrtillus L. is on the list of plants allowed in food supplements (Order of 24 June 2014).
ANSES opinion of 19 April 2023 on this plant: see its page.
fresh fruitOther ingredient, not identified in our sources100 mgAmount read: 100 mg. Daily basis unknown: no comparison with daily reference values.
Black Cohosh (Actaea racemosa extract 40 mg) equivActaea racemosa L.not statedActaea racemosa L. is on the list of plants allowed in food supplements (Order of 24 June 2014). Restriction: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
dry root & rhizomeOther ingredient, not identified in our sources200 mgAmount read: 200 mg. Daily basis unknown: no comparison with daily reference values.
Cranberry (Vaccinium macrocarpon fruit powder 20 mg) equivVaccinium macrocarpon Aitonnot statedVaccinium macrocarpon Aiton is on the list of plants allowed in food supplements (Order of 24 June 2014).
fresh fruitOther ingredient, not identified in our sources1,000 mgAmount read: 1,000 mg. Daily basis unknown: no comparison with daily reference values.
Ginger (Zingiber officinale extract 3 mg) equivZingiber officinale Roscoenot statedZingiber officinale Roscoe is on the list of plants allowed in food supplements (Order of 24 June 2014).
ANSES opinion of 19 April 2023 on this plant: see its page.
dry rhizomeOther ingredient, not identified in our sources15 mgAmount read: 15 mg. Daily basis unknown: no comparison with daily reference values.
Ginkgo (Ginkgo biloba extract 20 mg) equivGinkgo biloba L.not statedGinkgo biloba L. is on the list of plants allowed in food supplements (Order of 24 June 2014). Restriction: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
ANSES opinion of 19 April 2023 on this plant: see its page.
dry leafOther ingredient, not identified in our sources1,000 mgAmount read: 1,000 mg. Daily basis unknown: no comparison with daily reference values.
Globe Artichoke (Cynara scolymus extract 1 mg) equivCynara scolymus L.not statedCynara scolymus L. is not on the plant list of the Order of 24 June 2014: this is not a prohibition (a product legally sold in another Union country may contain it).
ANSES opinion of 19 April 2023 on this plant: see its page.
fresh leafOther ingredient, not identified in our sources50 mgAmount read: 50 mg. Daily basis unknown: no comparison with daily reference values.
Grape Seed (Vitis vinifera extract 9.9 mg) equivVitis vinifera L.not statedVitis vinifera L. is on the list of plants allowed in food supplements (Order of 24 June 2014).
ANSES opinion of 19 April 2023 on this plant: see its page.
dry seedOther ingredient, not identified in our sources1.18 gAmount read: 1.18 g. Daily basis unknown: no comparison with daily reference values.
Milk Thistle (Silybum marianum extract 21.43 mg) equivSilybum marianum (L.) Gaertn.not statedSilybum marianum (L.) Gaertn. is on the list of plants allowed in food supplements (Order of 24 June 2014).
ANSES opinion of 19 April 2023 on this plant: see its page.
dry fruitOther ingredient, not identified in our sources1.5 gAmount read: 1.5 g. Daily basis unknown: no comparison with daily reference values.
Turmeric (Curcuma longa extract 5 mg) equivCurcuma longa L.not statedCurcuma longa L. is not on the plant list of the Order of 24 June 2014: this is not a prohibition (a product legally sold in another Union country may contain it).
ANSES opinion of 12 May 2022 on this plant: see its page.
BfR opinion of 14 December 2021 on this plant: see its page.
dry rhizomeOther ingredient, not identified in our sources112.5 mgAmount read: 112.5 mg. Daily basis unknown: no comparison with daily reference values.
Water Hyssop (Bacopa monnieri extract 1.25 mg) equivBacopa monnieri (L.) Wettst.not statedBacopa monnieri (L.) Wettst. is on the list of plants allowed in food supplements (Order of 24 June 2014).
dry herb 50 mg.Note: g microgramsOther ingredient, not identified in our sourcesnot statedno reference

No dose reference in our sources for this name: it is not linked to any vitamin, mineral, plant or additive on our lists.

NRV: nutrient reference value, the daily reference intake for an adult set by Regulation (EU) No 1169/2011. Maximum dose in France: daily ceiling for a food supplement (Order of 9 May 2006). EFSA limit: intake not to be exceeded each day over the long term, including food.

During pregnancy or breastfeeding, or when taking medication, ask a doctor or pharmacist before taking a supplement.

Brand : Swisse

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Ultivite Women's 50+ Multivitamin Tablets (Swisse): composition and ingredients”, https://compoatlas.com/en/supplements/barcodes/93566780-ultivite-women-s-50-multivitamin-tablets-swisse, updated 10 June 2026.

Enter to analyse, Shift+Enter for a new line